Krsnaa Diagnostics Limited has informed the Exchange about General Updates
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.5 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Krsnaa Diagnostics has allotted 43,000 secured, unlisted, unrated, redeemable Non-Convertible Debentures (NCDs) of face value INR 1 lakh each, aggregating to INR 430 crore, to Asian Development Bank (ADB) on a private placement basis. The NCDs carry a coupon of 7.79% per annum and have a 7-year tenure maturing on February 23, 2033. Principal and interest will be paid half-yearly, with redemption in 13 equal installments starting 6 months from allotment. The debentures are secured by a charge over identified company assets. This is a continuation of the company's earlier communication dated December 12, 2025 regarding the NCD issuance.
Brings in INR 430 crore of long-term funding from a reputed multilateral institution, strengthening the balance sheet for business expansion, but adds debt of ~INR 33.5 crore in annual interest cost and increases leverage on the books. Existing shareholders may view this positively given the low cost of borrowing and quality of the investor (ADB), though there is no equity dilution.